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Introduction 
Why Biodegradable Stents? 
Cardiovascular disease is still the leading cause of death in industrialized countries 
and is expected to become so in emerging countries by 202053; chronic stable angina 
is its most common symptom52. 
Myocardial revascularization, or the restoration of adequate blood flow, plays a key 
role in the management of chronic stable angina. There are two procedures currently 
available for myocardial revascularization: coronary artery bypass graft (CABG) and 
percutaneous transluminal coronary angioplasty (PTCA). CABG is a surgical 
treatment performed on obstructed coronary arteries by grafting healthy vessels in 
order to bypass a blockage. The second procedure, PTCA, was introduced years later 
as a less invasive alternative to CABG; after placing a guiding catheter through the 
femoral, brachial or radial artery at the origin of the coronary artery, a balloon-tipped 
catheter is introduced into the coronary artery and inflated in order to expand the 
coronary artery wall at the site of the blockage, restoring normal blood flow. 
PTCA is now the most popular treatment, though CABG has been the treatment of the 
choice for patients with certain types of indications20. Advantages of PTCA include 
being less invasive, more cost effective34, having shorter recovery times, and its 
feasibility in acute myocardial infarction (MI) and high-risk coronary artery disease 
(CAD) patients. Comparisons of both methods in long-term outcomes shows that 
PTCA requires more repeat target vessel revascularizations (TVRs) due to the high 
number of acute vessel closures caused by coronary artery dissection, elastic recoil 
and restenosis14, which all occur as a result of vascular tissue injury caused by 
angioplasty. In order to overcome this limitation, bare metal stents were introduced. 
The advent of coronary stents (tubular wire mesh for intravascular mechanical 
support) has led to a new era in interventional cardiology. By implanting bare metal 
stents (BMS), all three limitations of PTCA – coronary artery dissection, elastic recoil 
and negative remodeling – are prevented83. It turned out, however, that implantation 
of bare metal stents brought some other major drawbacks with it: stent thrombosis and 
in-stent restenosis. Stent thrombosis is defined as a clot formation within the tubular 
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meshwork and can be effectively prevented through administration of dual antiplatelet 
therapy with ticlopidine and aspirin11, 50, 30. In-stent restenosis, on the other hand, is a 
result of deep focal vascular injury caused by stent struts, followed by excessive 
tissue proliferation38. There have been a number of different strategies developed to 
overcome this drawback.  
The first and most effective strategy developed to overcome in-stent restenosis was 
brachytherapy (β and γ radiation delivered intracoronary to inhibit cell proliferation). 
This, however, led to stent thrombosis due to the failure of vascular tissue healing, 
and further restenosis at the stent edges caused by the proliferative effect of low dose 
radiation4. It wasn’t until the invention of drug-eluting stents (DES) that 
interventional cardiology witnessed another breakthrough; and this novel innovation 
reduced in-stent stenosis rates drastically36.   
DES are essentially BMS coated with either anti-proliferative (eg. Paclitaxel) or 
immune modulating drugs (eg. Sirolimus substances) used to inhibit the biological 
processes responsible for in-stent stenosis. This technology has its own disadvantages: 
late malapposition, hypersensitivity reaction, chronic inflammation, elimination of 
vasomotion, and late stent thrombosis (after 1 year)4, 41, 55, 36. Another downside of 
DES, like all permanent stents, is that they are not compatible with computed 
tomography (CT) or magnetic resonance imaging (MRI) and to some extent preclude 
future surgical revascularization. 
To overcome the inherent limitations of permanent stents (in-stent stenosis, late 
thrombosis and elimination of vasomotion), the medical industry has been investing 
heavily in new technologies. Based on data from studies employing intravascular 
ultrasound (IVUS), stent scaffolding for the prevention of restenosis is required to last 
for 6 months63. Therefore the ideal stent would fulfill its mission and step away12 
through biodegradation. These so-called biodegradable stents should be 
biocompatible (able to perform with an appropriate host response in a specific 
application)64, as must be the product of their degradation, and they must provide 
proper scaffolding, radial force and endurance.  
The first biodegradable stent was introduced by Stack et al. in 1988 using a polymer 
of poly-L-lactide (PLLA)75. Unfortunately, histopathological studies showed that 
implantation of these stents resulted in significant inflammatory responses and 
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neointimal proliferation with extensive cell infiltration, suggesting that PLLA was not 
completely biocompatible. In addition, there was also evidence of medial necrosis and 
pseudoaneurysm formation79. In 2001, an experiment with New Zealand white rabbits 
showed that biodegradable iron stents could be applied safely without significant 
obstruction of the stented vessel caused by inflammation, neointimal proliferation, or 
thrombotic events60, though further clinical data is needed. 
In the years following, Heublein et al. introduced biodegradable magnesium stents33, 
a type of absorbable metals stent (AMS), which have since become an area of interest 
for numerous studies16, 59, 5, 80, 23, 24. Biodegradable magnesium stents have revealed 
both reduced intimal proliferation and larger minimum lumen diameters than BMS24. 
Later, Erbel et al. showed the feasibility and safety of biodegradable magnesium 
stents23. 
This brings us to the present day; before biodegradable magnesium stents can be 
introduced as a standard method for the treatment of coronary artery disease (CAD), 
more research is required to better understand the degradation kinetics and 
mechanical stability of these stents. It is also necessary to study the neointimal 
formation, inflammatory response of vessel walls to stenting and endothelialization of 
the stent struts. In order to accomplish these studies, however, the biodegradable 
magnesium stents must provide adequate opacity for visualization – wherein lies the 
challenge. It is not possible to visualize magnesium stents with coronary angiography, 
computed tomography (CT) or magnetic resonance imaging (MRI). Newer imaging 
modalities such as optical coherence tomography (OCT) and intravascular ultrasound 
(IVUS) have been proposed to exploit the ability of magnesium and its degradation 
products to reflect both light and sound23, 61 in order to visualize their degradation.  
The purpose of this research was to compare IVUS and OCT as in-vivo visualization 
techniques to capture the degradation progress and endothelialization of stent struts, 
and vessel geometry. To validate the results acquired with IVUS and OCT, histology 
was employed as an ex-vivo technique. And finally in order to capture the 
degradation process and kinetics at a cellular level, an alternative technique to the 
immersion and electrochemical test (the standard test for degradation studies), titan 
yellow staining, was also investigated. 
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IVUS (Intravascular Ultrasound) 
IVUS is a catheter-based visualization technique that provides cross-sectional 
imaging of coronary vessels. A transducer is positioned at the end of the IVUS 
catheter. There are two different types of the IVUS transducer available: a mechanical 
transducer (a single transducer rotates with fixed array system on a drive shaft) and 
electronically switched multi-element array system. The array system contains of 
piezoelectric crystalline material that contract and expand to create sound waves when 
electrically stimulated49. Ultrasound images are produced by passing a current 
through these crystals. This in-vivo visualization technique uses a rotating ultrasound 
probe attached to the tip of a specially designed catheter to emit ultrasound 
perpendicular to the vessel walls (for a range of frequency between 20 and 40 MHz, 
the typical image resolution is 150-250 µm). Two factors are essential for the image 
quality: spatial resolution and contrast resolution. While spatial resolution describes 
the discrimination of small objects within the image, contrast resolution is the 
distribution of the gray scale of the reflected signal49. On an IVUS image a healthy 
vessel wall is displayed two layered: intima and media are displayed as one single 
echolucent intima-media complex because those two layers cannot be differentiate 
well in a 150 µm - 250 µm resolution. Adventitia is displayed as a single echogenic 
layer74, 56. 
IVUS enables exact assessment of vessel wall morphology and vessel geometry with 
low intra- and inter-observer variability65. It is considered superior to coronary 
angiography because it can detect areas of positive remodeling (increases in external 
elastic membrane (EEL)), which is of interest because an increase in EEL may be 
indicative of over-compensation from increasing plaque areas associated with high-
risk of plaque rupture58, 57. 
One disadvantage of IVUS is its low accuracy in imaging particular areas, such as 
behind stent struts, due to acoustic shadowing and artifacts resulting from different 
impedance between the vessel wall and stent strut. Another is that its use in the 
assessment of neointima formation is also limited due to its relatively low axial-
resolution (50µm)21. 
Despite these disadvantages, during the past decade IVUS has proved to be the 
standard of reference for qualitative assessment of coronary vessels due to its high 
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accuracy26, 29, 47. In particular, IVUS has helped determine the mechanism of in-stent 
stenosis73 and plaque characteristics (concentric, eccentric, calcified)25. Finally, IVUS 
has also been instrumental in the visualization of biodegradable stents and in 
quantifying stent parameters for the qualitative assessment of its degradation 
process16, 22, 23, 24, 33. 
OCT (Optical Coherence Tomography) 
OCT is an in-vivo infrared light-based imaging modality that relies on the use of 
interferometry - a technique used to measure light velocity. OCT utilizes an infrared 
light source (1300±50 nm wavelength) that is sent through a fiber optic and then split 
in to two arms: a sample arm and a reference arm. The sample arm reflects the 
transmitted light rotated through 360° in the vessel to provide a two-dimensional 
image. The interferometer combines the light returning from the sample arm with that 
of the reference arm in order to create an interference pattern containing information 
about the intensity of the optical back-scattering, displayed as a (false) color or gray 
scale image. Thus, OCT provides a two-dimensional (2D) cross-sectional real-time 
image. Both the bandwidth of the employed infrared light and the wave velocity are 
higher than in medical ultrasound and its typical resolution is 10microns8, meaning it 
can provide in-situ images of tissues at near histologic resolution. 
In the early 1990s, OCT was first applied in the field of ophthalmology37. Its 
subsequent vascular applications in the mid-‘90s demonstrated the potential of the 
technique to identify clinically relevant coronary artery morphology with a level of 
resolution higher than any other clinically available diagnostic imaging modality8, 39. 
A healthy non- atherosclerotic vessel presents three layers on OCT. Intima is 
displayed as bright and high reflective band. Media has a weak signal intensity, while 
adventitia has a stronger signal intensity7. Thanks to this high-resolution tomographic 
intra-arterial imaging, OCT has proven to be accurate in characterizing atheromatous 
plaque in a histology-controlled study81 and also in identification of plaques with thin 
fibrous cap (having high rupture risks)40. Additionally, OCT can both assess the effect 
of coronary artery stenting with BMS, DES and AMS62, 76 and visualize the complex 
coronary arterial wall structure after stenting in much greater detail than IVUS6, 78, 48. 
One of the main drawbacks of OCT is its limited penetration depth, which effectively 
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makes a blood-free environment a requisite for proper imaging. As a non-transparent 
tissue, red blood cells in the coronary artery cause scattering that results in signal 
attenuation7 due to the mismatch of refractive indexes between red blood cells and 
serum. Several techniques, including balloon occlusion and intra-coronary flush, have 
been developed to address this limitation and evacuate the blood during examination. 
While both these techniques have been linked to a risk of ischemia in the examined 
area, intra-coronary flush has been associated with fewer complications42. Alternative 
methods, including automated catheter pullback at a very high speed and index 
matching through raising the index of serum, are now under investigation to mitigate 
these risks7. 
While there are currently no established guidelines for the clinical use of OCT, it has 
already been applied as the standard of reference in a number of studies: PCI guide 
and optimization77, as well as assessment of tissue coverage of stent struts84, plaque 
compositon81 and innovative stent design61. Most recently, a study by Yamaguchi et 
al. demonstrated that OCT is a safe and feasible technique for use in humans, paving 
the way for its potential to become a gold standard in assessing lumen dimensions of 
coronary arteries82. 
Histology 
Histology is the standard of reference46, 18, 61 for the validation of in-vivo findings (ie. 
vessel morphometry and anatomy) in cardiovascular medicine. After the tissue of 
interest is collected from the subject, it is prepared with a fixative (either chemical or 
frozen) and stained with an appropriate dye based on the specific question to be 
answered. The aim of histological staining is to capture microscopic tissue details, 
and in this study we applied Movat’s pentachrome for the comparison of the in-vivo 
findings15 because it is a validated method that can reliably assess the vessel both 
qualitatively and quantitatively67. 
To understand and improve the mechanical stability of AMS, it is imperative to 
understand their degradation kinetics. In previous studies of degradation kinetics, the 
immersion and electrochemical tests32 have been the two most commonly used in-
vitro methods, while IVUS and OCT have been the most common in-vivo methods61. 
The immersion test2 evaluates the corrosion of materials in aqueous solutions by 
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assessing, for example, their weight over an exposure time. Electrochemical tests on 
the other hand use an electrolyte solution to measure the oxidation/reduction 
reactions1. Beyond studying the biodegradation of magnesium stents, it is also 
imperative to capture the distribution of magnesium degradation products within the 
vessel to quantify their possible adverse effect. However, there is no established 
method that can answer this question and a histopathological technique that 
specifically visualizes the magnesium may help us do just that; this was in fact the 
second specific aim of this study. 
Specific Aims 
The goal of this study was twofold: 
1. To examine the properties as well as possible advantages and disadvantages of 
intracoronary imaging modalities (i.e. OCT and IVUS) for the assessment of 
the degradation process of magnesium based biodegradable stents 
2. To compare these findings with histology and to develop a histopathologic 
method to assess the magnesium distribution in the vascular tissue following 
the degradation process.  
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Methods 
Animals and Procedure 
For these studies an animal model with a similar coronary anatomy to that of humans 
was employed. This model consisted of 4 Gottingen minipigs with a mean age of 24.3 
months and a mean weight of 55±3.57 kg. The aim was to implant stents into all three 
coronary vessels of each pig, using one BMS (bare metal stent) and two AMS 
(absorbable metal stent) per pig. The assignment of stents to particular vessels was 
made at random. 
To prepare the animals for stent implantation, they were sedated with an 
intramuscular injection of ketamine (20 mg/kg) and xylazine (2 mg/kg) while 
intubated and ventilated with oxygen (2 l/min) and isoflurane (1.5 - 3.0%). After a 
single dose of heparin (150 U/kg) was administered, the femoral artery was 
cannulated using the Seldinger technique to gain femoral access. Through this access, 
the stents were deployed using a 6-French (6F) guiding catheter under fluoroscopic 
guidance into the left anterior descending artery (LAD), the left circumflex artery 
(LCx), and the right coronary artery (RCA). Points of interest for stenting were vessel 
segments with a 2.5-3 mm diameter that were also 5 mm away from any branching. 
Once in position, the stents were expanded to a diameter of 3 mm with the use of a 
high-pressure balloon at 16 bar (intended balloon to artery diameter ratio of 1.2 – 1.4 
was used to induce restenosis by overexpansion of the vessel). Upon completion of 
stent implantation, a coronary angiography was performed and recorded for precise 
documentation of stent positioning (along with administration of 0.25 mg of 
nitroglycerin to prevent possible coronary spasm). 
For visualization at the time of stent implantation, IVUS and OCT were performed. 
Data acquisition was performed during the automated and motorized pullback of the 
catheter and all images were archived digitally for offline analysis. Potential problems 
during the examination of the coronary vessel include the automatic pullback, 
compression, and movement of the fiber optics, which all can reduce the accuracy of 
dimensional measurements with OCT. To overcome these potential sources of error, 
both OCT and IVUS probes were calibrated with the aid of a test block.  
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Once the initial imaging was complete, the femoral access was closed with a 
dedicated closure device (AngioSeal™, St. Jude Medical, Minnetonka, Minnesota, 
USA) and the animals were roused from anesthesia. For the next four weeks, they 
were treated daily with Aspirin (100 mg) and Clopidogrel (75 mg) in order to prevent 
stent thrombosis. 
The next imaging phase was intended at the end of the study, 4 weeks after 
implantation. The same in-vivo examinations using IVUS and OCT were conducted, 
along with coronary angiography, on the stented coronary arteries. In order to proceed 
with ex-vivo imaging the animals were sacrificed and the stents were explanted along 
with the coronary arteries from the harvested hearts, which were subsequently flushed 
with an isotonic NaCl solution to clear the remaining blood. The stent-carrying 
coronary arteries were placed in translucent test tubes and kept in a fluid nitric acid-
filled container in order to freeze and preserve them for histology. 
 
Figure 1: Location of stents with x-ray prior to histology. BMS in the middle; AMS on each side. Before 
continuing to the planned ex-vivo studies, an x-ray was performed on the thawed stented coronary vessels in order 
to locate the stents and evaluate their structural integrity. While the low opacity of the AMS made them 
challenging to visualize, generating an under voltage in the x-ray generator (40 kV and 0.50 mAs) provided 
adequate images for this evaluation. Figure 1 below displays the resulting x-ray image (BMS in the middle test 
tube and AMS on each side shown faintly). With x-ray complete, the vessels were refrozen at -80°C. 
Coronary Stents 
Bare Metal Stents (BMS) 
The BMS (PRO-Kinetic, Biotronik, Bülach, Switzerland), used in this study had a 
diameter of 3mm, length of 10mm and a strut thickness of 60µm (Figure 2). The 
stents were composed of cobalt chromium with a silicone carbide coating 
- 10 -
(PROBIO®), had a double helix design, and were deployed with the use of an 
expandable balloon catheter. 
  
Figure 2: A. PRO-Kinetic cobalt chromium stents before implantation (ex-vivo expanded), B. Low kilo voltage 
radiographs of porcine coronary arteries implanted with BMS (28 days after implantation)61. 
Magnesium Alloy Stents (AMS) 
The AMS (Progress, Biotronik, Bülach, Switzerland) used in this study had wave-
shaped segments around their circumference that in turn connected to one another by 
longitudinal straight segments (Figure 3). The stents are crafted from a single tube 
using a laser, and are composed of 93% magnesium, 3.7 - 5.5% yttrium, and 1.5 - 
4.4% other rare earth elements. Due to its opacity, two radio-opaque markers are 
attached to the both ends of it. Their complete biodegradation can range from 60 to 90 
days19 depending on the composition of the aforementioned components, and upon 
degradation resolve to: magnesium-hydroxyappatite, -chloride, -oxide, -sulfate, or -
phospate. Animal studies have shown that these products, as well as the stent 
themselves, are biocompatible24. They have a low elastic recoil (<8%) and minimum 
shortening after inflation (<5%)19. Their dimensions were identical to BMS, as was 
their implantation technique. 
  
Figure 3: A. AMS before the implantation (ex-vivo expanded), B. Low kilo voltage radiographs of porcine 
coronary arteries implanted with AMS (28 days after the implantation)61. 
A
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Intravascular Ultrasound (IVUS) 
Equipment 
The IVUS device, an S5 Imaging System (Volcano Corp., Rancho Cordova, CA, 
USA, Figure 4A), contains an imaging catheter, a motorized pullback device, an 
imaging console, and an external signal processing system. The IVUS operates at a 
frequency of 20-40MHz, provides a resolution of 150-250µm and has a penetration 
depth of 8mm. The imaging catheter on the device can use one of two different IVUS 
transducers: a mechanically rotating transducer, or an electronically switched multi-
element array system. The one used in this experiment, an Eagle Eye Gold Catheter 
(Volcano Corp., Rancho Cordova, CA, USA, Figure 4B) uses the latter. The catheter 
employs an angiography guide wire that allows for intracoronary insertion, and uses a 
64-element transducer with an array of crystal situated annularly at the edge of the 
imaging catheter itself. One set of the elements in this array transmits the sound, 
while a second set receives it simultaneously49. 
  
Figure 4: A. IVUS S5 Imaging System (Volcano Corp., Rancho Cordova, CA, USA), B. Eagle Eye Gold Catheter 
(Volcano Corp., Rancho Cordova, CA, USA) with multi element array system transducer (∗). 
Study 
For visualization at time of stent implantation, an IVUS catheter was placed with the 
use of a guiding catheter at the distal end of the stent in the implanted coronary artery 
under fluoroscopic guidance. In order to scan the vessel lengthwise, the catheter-
imaging tip was pulled back at an automatic constant speed between 0.5 mm/s (Trak 
B
*
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Back II, Volcano Corp., Rancho Cordova, CA, USA). Thanks to the electronic 
transducer system used no non-uniform rotational distortion (NURD) artifacts could 
occur. Ring-down artifacts – bright halos of variable thickness surrounding the 
catheter – can be removed automatically by using the integrated NearVu software. 
The acquired data was archived in the DICOM (digital imaging and communications 
in medicine) format for offline studies. 
To compare IVUS, OCT, and histology, images from each millimeter of the stented 
areas were used (eleven cross-sectional images). 
Dimensions 
• Stent area (mm2): Area between connecting lines of the outer and inner edges 
of the stent. 
• Min lumen diameter (mm): Minimum diameter of the lumen-intima border  
• Max lumen diameter (mm): Maximum diameter of the lumen-intima border 
• Strut number (#): Number of stent struts within a cross-section  
• Strut thickness (mm): Mean axial diameter of 3 randomly chosen struts from 
each cross-section  
Analysis Software 
Images acquired with IVUS were analyzed using Tape Measure (Indec Systems, 
Mountain View, CA, USA), a commercially available software for the computerized 
planimetry of coronary arteries. The images acquired with IVUS were imported into 
Tape Measure and were calibrated using a raster from the image data. The exact 
location of each image was determined by using the time display on the image and 
known pullback rate of the catheter. 
Optical Coherence Tomography (OCT) 
Equipment 
Similar to IVUS, the equipment for the intracoronary OCT System (M2 LightLab 
Imaging Inc., Westford, USA, Figure 5) consists of an imaging catheter, a motorized 
pullback device, an imaging console (containing light source), signal processing units, 
data storage and display. The OCT uses broadband infrared light with a wavelength of 
1300±50 nm. Its resolution is 15 µm and it has a penetration depth of 2mm. 
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Figure 5: OCT System (M2 LightLab Imaging Inc., Westford USA) 
An over-the-wire occlusion catheter (Helios, Goodman &Co. LTD., Japan, Figure 6) 
was used to clear the examined coronary artery of blood. The inside of the occlusion 
catheter was hollow, allowing not only for the insertion of the guiding catheter and 
the OCT imaging catheter, but also for the segment of interest to be flushed with the 
isotonic NaCl or Ringer’s Lactate solution. During imaging, the low-pressure 
occlusion balloon catheter is positioned proximal to the examined segment and is 
inflated at 0.3atm. Simultaneously, the coronary blood flow is evacuated by 
continuous flush of isotonic NaCl solution. The vessel occlusion time is limited to 30 
seconds to avoid any ischemia or arrythmia. 
 
Figure 6: Schematic illustration of occlusion balloon catheter (Helios, Goodman & Co. LTD. Japan). 
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The imaging catheter (Imaging Wire, LightLab Imaging Inc. Westford, USA) 
contains a translucent casing that itself contains a single-mode optical fiber. The tip of 
the catheter directs the optical signal with the use of a microprism lens at the vessel 
wall. Additionally, the catheter has a 15mm radiopaque tip situated slightly away 
from its distal segment in order to identify its position as it lacks adequate opacity 
under fluoroscopy. As the imaging catheter rotates and is retracted (at 1 mm/s) from 
the coronary artery, a tomographic cross-sectional image is captured along a length of 
30nm in a single run.  
Study 
Upon completion of IVUS, the over-the-wire occlusion balloon catheter of the OCT 
was placed over the same guiding catheter and slid to the stented segment. The 
guiding catheter was then removed, and the imaging probe of the OCT was inserted 
through the lumen of the occlusion balloon distal to the segment of interest. To 
prepare for clearing the coronary vessel of blood, the occlusion balloon was then 
pulled back into the proximal segment. Just prior to image acquisition, the balloon 
was inflated to 0.3 bar to block blood flow, and a solution of isotonic NaCl at body 
temperature was flushed through the end-hole of the occlusion balloon catheter to 
evacuate the blood remaining in the coronary artery. Once cleared of blood, the 
imaging probe visualized the stented vessel as it was removed distally at a speed of 1 
mm/s. All acquired OCT images were archived digitally for offline examination. 
Dimensions & Analysis 
The same dimensions as IVUS were also acquired for OCT images. This data was 
analyzed similarly to IVUS with Tape Measure (Indec Systems, Mountain View, CA, 
USA). 
Histology 
Movat’s Pentachrome Stain (MPS) 
Equipment 
The pentachrome stain was originally developed by Movat in 1955 as a single 
histochemical stain to isolate and visualize the different components of tissue51. The 
major elements of MPS are: Verhoeff elastic hematoxylin, sodium thiosulfate, acetic 
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acid, alcian blue, crocein, scarlet–acid fuchsin and alcoholic saffron solutions66. MPS 
enhances vessel wall structure, especially the elastin and smooth muscle 
components67, and in doing so facilitates detection of otherwise easy-to-miss vascular 
pathology. 
Study 
The stented coronary vessels were prepared for the histological study with the aid of 
cryosectioning, a technique used to cut tissue in frozen state with a microtome knife 
within a cryostat. The advantage of the cryosectioning procedure over using a fixative 
is that the frozen tissue degrades much slower and does not alter nor mask its 
chemical composition as much. The vessel of interest was placed on a metal tissue 
disc that is then secured in a chuck. The specimen is then embedded in a gel like 
medium consisting of poly ethylene glycol and polyvinyl alcohol; this compound has 
the same density as frozen tissue when frozen. With the use of a standard steel 
microtome knife, the frozen coronary vessels with implanted AMS were sliced into 
10µm-thick segments, starting 5mm proximal of the stented segment to 5mm distal to 
it (resulting in 200 segments, as the stents were 1 cm). The segments were mounted 
on glass slides, photographed (AxioCam HRC, Carl Zeiss Germany) in a native state, 
then stained (see Figure 7) with Movat’s pentachrome as described in the following 
paragraph and then re-photographed to isolate any morphology changes attributable to 
the staining procedure. All images were archived in jpeg format. 
The slides were first left to dry in ambient air overnight. Then, after fixation in a 70% 
alcohol bath for five minutes, they were left to air-dry for another 30 minutes and 
finally photographed in their native state. 
The staining procedure employed was a small modification to Movat’s Pentachrome 
stain that minimized the corruption of AMS due to water and alcohol: 
The staining began with hydration to distilled water for three minutes to remove any 
remaining alcohol45. After pre-treating the slides in acetic acid (3%) for 30 seconds, 
they were placed for 30 minutes in alcian blue (Sigma) to stain the ground substance. 
Upon washing off the rest of this stain under running water for 1 minute, the staining 
continued in the Vorheoff’s solution for nine minutes, in order to differentiate the 
elastic fibers and nuclei. The Vorheoff’s Stock solution consisted of four different 
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solutions that have to be made fresh daily. The working solution uses orcein (Merck) 
and hematoxylin (Sigma) as dyes. The slides were then dipped in in 1% aqueous 
ferric chloride (Merck) for one minute to differentiate. Upon being rinsed briefly in 
running water, the slides were then placed in the crocein scarlet-acid fuchsin (Fluka) 
(consisting of 2 separate solutions: crocein scarlet and acid fuchsin) for three minutes 
to stain the muscles and fibrin, and then rinsed in acetic acid (1%) to fixate. Then the 
slides were differentiated in 2% aqueous phosphotungstic acid for 15 min. The 
phosphotungstic acid was removed with the use of 1% acetic acid. After dehydrating 
in 100% alcohol for two minutes, the slides were stained in saffron for 6 minutes to 
stain the reticular fiber and collagen to yellow, followed finally by dehydration in 
100% alcohol for five minutes and mounted in entellan (Merck) and Canada balsam. 
As it has been shown in many studies that the different phases of histological 
preparation often affects the dimensions of coronary arteries17,10, in order to determine 
the effect of staining on the vessel morphometry for this study both native and stained 
cross-sectional images were compared. 
For intra-observer reproducibility, one observer repeated an identical analysis on the 
histological segments after an interval of three months. 
 
Figure 7:  Scaled for histological vessel morphometry (AxioCam HRC, Carl Zeiss Germany). Colors are as 
follows: Nuclei and elastic fibers are black, collagen and reticular fibers are yellow, ground substance and mucin 
are blue, fibrinoid and fibrin are intense red, and the muscle is red.  
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Dimensions 
• Min lumen diameter (mm): Minimum diameter of the lumen-intima border  
• Max lumen diameter (mm): Maximum diameter of the lumen-intima border 
• Mean lumen diameter (mm): Mean diameter of the lumen-intima border 
• Strut number (#): Number of the stent struts in a cross section  
• Strut area (mm2): Area of a stent strut 
• Lumen area (mm2): inner area left between lumen-intima border 
• Intima area (mm2): area between intima-media border 
• Vessel area (mm2): area between media-adventitia border 
Analysis Software   
AxioVision (Carl Zeiss Inc., Germany) was the software used to perform the 
planimetry of the histology samples. Images of the samples were acquired directly 
from the microscope thanks to its integrated camera controls. The software’s 
interactive histogram and image processing tools helped to optimize color and 
contrast. Because the software reads and writes in ZVI-format, the digital images are 
processed and saved with a loss-free wavelet algorithm, meaning the images are 
uncompressed in contrast to generic file formats like TIF or JPEG. The ZVI format 
also ensures that other pertinent information, e.g. annotations or magnification, is also 
saved along with the pixel data in a single file (Carl Zeiss). 
Titan Yellow Stain 
Equipment 
Titan yellow is a triazene dye used as a stain and fluorescent indicator that helps to 
detect magnesium70. The stain changes its color from yellow to orange/red in the 
presence of magnesium. 
In 1927, Kolthoff described magnesium’s reddish-orange appearance upon reaction 
with alkaline solutions44. Later in 1951, Craig used the same method to detect 
magnesium in serum and plasma13. Glick, Freier and Ochs were later able to detect 
magnesium in adrenal glands with the use of a photometric micro-procedure27. More 
recently, in 1991, Müller and Firsching demonstrated that Titan yellow reliably 
detects magnesium in tissues with elastic fibers51.  
In this study we applied this method to detect and demonstrate the biodegradation of 
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the magnesium alloy stents. The major components of this stain were titan yellow 
solution (5% thiazole yellow, and sodium hydroxide NaOH), Weigert’s resorcin and 
orcein. While Weigert’s resorcin and orcein are not standard components of the Titan 
yellow stain, we employed them in this study in order to provide a strong contrast to 
better isolate the orange/red color of the magnesium. 
Procedure 
Once the slides were prepared with the use of cryosectioning they were photographed 
in their native state, hydrated with distilled water for 15 minutes, fixed in a 70% 
alcohol bath for five minutes, and then placed in the Titan yellow solution for 20 
minutes. After rinsing the slides with distilled water they were immersed in the 
Weigert’s resorcin solution for three minutes, and then washed under running water. 
Finally, the slides were immersed in the orcein solution for two minutes to complete 
the staining. The slides were differentiated first as follows: in 96% alcohol, 100% 
alcohol and xylol each for five minutes and then mounted with Vectashield®. As 
mentioned before, magnesium is indicated by an orange-red color and this reaction 
occurs within minutes. The stained slides were visualized with the aid of a 
fluorescence microscope (Zeiss Axiotech Vario, Germany), photographed with a 
camera (AxioCam HSm, Carl Zeiss Germany), and filtered for DAPI (excitation at 
360 nm and emission at all wavelengths) to examine the biodegradation process 
(Figure 8). We were not interested in vessel morphometry. 
 
Figure 8: Titan yellow stained struts on a cross-section. Notice the orange-yellow colored AMS struts (+) 
surrounded by a thin endothelial coverage (*). Photographed on fluorescence microscope (Zeiss Axiotech Vario, 
Germany) with camera (AxioCam HSm, Carl Zeiss Germany) and DAPI filter.  
*
+
Lumen
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Statistics 
Statistical analysis was performed using SPSS 12.0.1 for Windows (SPSS, Chicago, 
IL, USA). The ANOVA-Test was used to compare dimensions between BMS and 
AMS, while the Bland-Altman approach was used to make comparisons between 
different imaging techniques. The significance level was determined to be 1% and 5% 
respectively. 
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Results 
Animals and Study 
For this study, four Gottingen minipigs were implanted with ten stents: 3 Bare Metal 
Stents (BMS) and 7 Magnesium Alloy Stents (AMS).  Table 1 gives an overview of 
the assignment of these stents. Two animals received three stents each, while two 
others received just two due to complications. Upon implantation of its second stent, 
Animal 92872 developed a ventricular tachycardia that was successfully treated, 
resulting in the third stent not being implanted as planned. Animal 73535 died during 
OCT imaging after implantation of two stents into its LAD and LCx. In order not to 
compromise the study, we did not continue with OCT imaging of the remaining two 
animals. At the time of the implantation, eight stents were assessed with the use of 
IVUS and two with OCT. 
After four weeks, IVUS and OCT visualization was repeated on the three remaining 
animals. Only seven out of the eight vessels could be studied with both IVUS and 
OCT, resulting in four AMS and three BMS being imaged. One stent in the LAD of 
animal 92872 could not be visualized prior to explantation due to the vessel being 
dissected and occluded during OCT at implantation. 
Upon completion of in-vivo imaging, the animals were sacrificed and their hearts 
were harvested for histological study.  
Animal Vessel Stent 
92872 
RCA - 
LAD AMS 
LCx BMS 
73448 
RCA AMS 
LAD AMS 
LCx BMS 
92879 
RCA AMS 
LAD AMS 
LCx BMS 
73535 
RCA - 
LAD AMS 
LCx AMS 
Table 1: Animal assignment of BMS & AMS implantation by vessel. 
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Implantation 
IVUS 
At implantation, eight stents were studied with the use of the IVUS: 3 BMS and 5 
AMS. The stent struts of both AMS and BMS were presented similarly, both 
echogenic with a distal acoustic shadowing. However, the echogenicity was lower for 
AMS. Neither stent type displayed any malapposition, dissection, thrombus or 
neointima formation (Figure 9). 
  
Figure 9: IVUS images of AMS (A) and BMS (B) at the time of implantation. The stent struts of both AMS and 
BMS were presented similarly, both echogenic with a distal acoustic shadowing. Neither stent type displayed any 
malapposition, dissection, thrombus or neointima formation. 
The following parameters were assessed with IVUS on the five AMS and three BMS: 
stent area, strut number, strut thickness and min and max lumen diameter. The mean 
value of each parameter can be found in Table 2. 
OCT   
As explained earlier, only two vessels could be imaged with OCT during 
implantation: one AMS and one BMS. Both stent struts presented as bright and highly 
reflective bands with distal shadowing. The AMS struts appeared slightly thicker than 
BMS struts, and had a better signal intensity.  Contrary to the IVUS results, the cross-
sectional OCT images displayed an incomplete apposition in both AMS and BMS 
A
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B
Lumen
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(Figure 10). Due to the limited number of samples, no standard deviation was 
calculated for this series. 
  
Figure 10: OCT images of AMS (A) and BMS (B) at the time of implantation. The AMS struts appeared slightly 
thicker than BMS struts, while both clearly displayed distal acoustic shadowing. Contrary to the IVUS results, the 
cross-sectional OCT images displayed an incomplete apposition in both AMS and BMS. 
Similar parameters to IVUS were assessed with OCT: stent area, strut number, strut 
thickness, and min and max lumen diameter. Unlike in IVUS, no standard deviation 
was calculated due to the limited numbers of stents assessed. The mean values of the 
parameters are shown in Table 2. 
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Table 2: Overview of morphometric parameters with IVUS und OCT during implantation 
Explantation 
IVUS 
At the time of explantation, there was no visible change in the appearance of BMS 
with IVUS. The AMS struts on the other hand showed clear signs of degradation, 
with a fainter appearance and a decline in distal acoustic shadowing. Some AMS 
struts could barely be discerned from the vessel wall, and complete endothelial 
Technique Type Parameter Visualized 
Stents 
Mean 
Value 
Standard 
Deviation 
IVUS AMS Stent Area 5 8.00 1.05 
  Strut Number 5 6.38 1.22 
  Strut Thickness 5 0.20 0.03 
  Max Lumen Diameter 5 3.16 1.19 
  Min Lumen Diameter 5 2.88 0.19 
 BMS Stent Area 3 6.31 0.66 
  Strut Number 3 8.88 2.18 
  Strut Thickness 3 0.19 0.03 
  Max Lumen Diameter 3 2.84 0.16 
  Min Lumen Diameter 3 2.59 0.14 
OCT AMS Stent Area 1 8.40 n.a. 
  Strut Number 1 8.00 n.a. 
  Strut Thickness 1 0.05 n.a. 
  Max Lumen Diameter 1 3.35 n.a. 
  Min Lumen Diameter 1 3.09 n.a. 
 BMS Stent Area 1 8.1 n.a. 
  Strut Number 1 4.55 n.a. 
  Strut Thickness 1 0.04 n.a. 
  Max Lumen Diameter 1 3.31 n.a. 
  Min Lumen Diameter 1 3.03 n.a. 
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coverage of struts was not visible (Figure 11). 
  
Figure 11:  IVUS images of AMS (A) and BMS (B) at the time of explantation. There was no visible change in the 
appearance of BMS with IVUS. The AMS struts on the other hand showed clear signs of degradation, with a 
fainter appearance and a decline in distal acoustic shadowing. Some AMS struts could barely be discerned from 
the vessel wall, and complete endothelial coverage of struts was not visible. 
The same parameters assessed at time of implantation were also assessed at the time 
of explantation (stent area, strut number, strut thickness, and min and max lumen 
diameter) for both AMS (four stents) and BMS (three stents). The mean value of each 
parameter in the IVUS is shown in Table 3. While no change was observed in BMS, 
the AMS stent area was significantly reduced (26%) over those 4 weeks. The strut 
number and strut thickness were also both reduced (30% and 30% respectively), and 
both the min and max lumen diameters were also reduced minimally (16% and 3%) 
(Table 4). 
OCT 
Seven vessels, the same amount as with IVUS, were analyzed with OCT: four AMS 
and three BMS. At the time of explantation, the incomplete apposition present at 
implantation was no longer apparent and there was thin endothelial coverage of the 
stent struts. Again the BMS appeared unaltered compared to implantation, while the 
appearance of the AMS was noticeably changed. AMS struts appeared darker and 
more diffuse. Some struts seemed to have dissolved and had less discernible distal 
shadowing (Figure 12). Due to the limited numbers of studies during implantation, a 
comparison between OCT at implantation and explantation was not feasible. 
A
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Figure 12: OCT images of AMS (A) and BMS (B) at the time of explantation. The incomplete apposition present 
at implantation was no longer apparent and there was a thin endothelial coverage of the stent struts. Again the 
BMS appeared unaltered compared to implantation, while the appearance of the AMS was noticeably changed. 
AMS struts appeared darker and more diffuse. Some struts seemed to have dissolved and had less discernible distal 
acoustic shadowing 
The same parameters were assessed at the time of implantation as at the time of 
explantation with OCT. Due to the limited number of vessels at the time of 
implantation, no comparison was made between the dimensions at the time of 
implantation and explantation. The mean value of each parameter in the IVUS is 
shown in Table 3. 
Histology 
Movat’s Pentachrome Stain (MPS) 
This ex-vivo study allows one to visualize AMS stented vessels. Three layers of 
vessel wall could be identified with the use of this stain. As indicated in methods, the 
endothelium surrounding the struts was displayed in blue, the vessel layers in red with 
varying intensity (based on composition of muscle and fiber), the adventitia in yellow 
(collagen), internal and external lamina elastic, and struts, were captured in black 
(Figure 13). The high resolution of MPS enables vessels to be assessed in detail and 
helps capture thrombus (Figure 14A, B) and neointima formation (Figure 15A, B, C) 
that could otherwise not be detected using another of the imaging techniques. 
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Figure 13: Three layers of vessel wall could be identified with the use of the stain. As indicated in the methods: the 
endothel surrounding struts was displayed in blue, the vessel layers in red with different accentuation (based on its 
content of muscle and fiber), the collagen around adventitia in yellow (collagen), the internal lamina elastica, 
external lamina elastica and struts in black (AxioCam HRC, Carl Zeiss Germany). 
 
 
Figure 14A: A platelet-rich thrombus adherent to the lumen.  Histology was the sole method employed in this 
study to visualize thrombus formation (AxioCam HRC, Carl Zeiss Germany). 
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Figure 14B: Note the platelets on the top of a complex of smooth muscle cells in a collagenous matrix. Due to its 
high resolution and this specific staining technique, vessel pathology could be reliably visualized (AxioCam HRC, 
Carl Zeiss Germany). 
 
 
Figure 15A: Eccentric lumen obstruction due to neointima hyperplasia (ie. migration of smooth muscle cells, 
platelets, leucocytes, and proliferation of extra cellular matrix) as a result of arterial wall injury after stent 
implantation (AxioCam HRC, Carl Zeiss Germany). 
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Figure 15B: A magnified section from Figure 15A. Note the smooth muscle cells (red) surrounding the struts. 
 
 
Figure 15C: Another magnified section of Figure 15A. Note the collagenous matrix (blue) produced by smooth 
muscle cells (AxioCam HRC, Carl Zeiss Germany) 
Due to technical difficulties, only AMS could be studied at the time of explantation. 
As a result of the histological processing, some struts were washed out so that there 
was no constancy among strut numbers at different positions. Additionally, a few 
samples were destroyed during the preparation, further reducing the number of cross-
sections from 33 to 19 available to study (Figure 16). 
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Figure 16: As result of the histological processing, a few samples were destroyed during preparation, further 
reducing the number of cross-sections available. Note also the wash-off effect of staining on the struts as seen by 
the empty strut lobes (AxioCam HRC, Carl Zeiss Germany) 
The maximum lumen diameter ranged from 1.10-2.32 mm with a mean value of 
1.75±0.29 mm. The minimum lumen diameter varied between 0.038-1.42 mm for a 
mean of 0.85±0.31 mm. For strut number, the mean value was determined to be 
7.5±2.17 while ranging from 3 to 25. And the mean strut area for was 0.03±0.01 mm2 
while varying between 0.02-0.06 mm2 (Table 3). 
 
 
 
 
 
 
 
 
 
	   - 30 -	  
 
Table 3: Overview of the dimensions in IVUS, OCT, CT and histology at the time of the explantation. 
 
 
Technique Stent 
Type 
Parameter Stents Mean 
Value 
Standard 
Deviation 
IVUS AMS Stent Area 4 5.93 0.48 
  Strut Number 4 4.45 1.47 
  Strut Thickness 4 0.15 0.02 
  Max Lumen Diameter 4 2.88 0.46 
  Min Lumen Diameter 4 2.69 0.37 
 BMS Stent Area 3 6.36 0.57 
  Strut Number 3 9.42 1.87 
  Strut Thickness 3 0.19 0.24 
  Max Lumen Diameter 3 2.69 0.31 
  Min Lumen Diameter 3 2.55 0.43 
OCT AMS Stent Area 4 4.33 1.59 
  Strut Number 4 6.20 2.08 
  Strut Thickness 4 0.05 0.006 
  Max Lumen Diameter 4 2.53 0.60 
  Min Lumen Diameter 4 2.16 0.63 
 BMS Stent Area 3 7.81 0.39 
  Strut Number 3 5.85 2.43 
  Strut Thickness 3 0.04 0.006 
  Max Lumen Diameter 3 2.45 0.53 
  Min Lumen Diameter 3 2.14 0.44 
Histology AMS Max Lumen Diameter 3 1.75 0.29 
  Min Lumen Diameter 3 0.85 0.31 
  Strut Number 3 7.5 2.17 
  Strut Area 3 0.03 0.01 
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Table 4: IVUS measurement comparison for AMS at implantation vs. explantation. 
Titan Yellow Stain 
Titan yellow stain was used to evaluate the bioabsorble struts separately (not the 
vessel layers) and also to observe/understand the biodegradation process. The titan 
yellow study was performed on 90 randomly chosen cross-sections of vessels stented 
with AMS. To avoid washing out the biodegradable stent struts, the staining 
procedure was modified so that the time for dehydration in ethanol baths was 
minimized. Under fluorescence microscopy the struts appeared orange, while the 
embedded endothelium appeared bluish-violet due to the combined staining with 
Weigert’s resorcin and orcein (Figure 17A, B).  
This method demonstrated the diffusion of the AMS degradation products to the 
surrounding tissue. Due to technical difficulties with the fluorescence microscope, 
only 25 cross-sections out of the original 90 could be studied. And 12 out of those 25 
cross-sections captured the diffusion of degradation products in to the surrounding 
tissue.  
Upon taking this study up again 3 months later, the stain was no longer strong enough 
to capture diffusion of the magnesium particles – only strong enough to identify the 
struts. Due to the variation of staining quality, no quantitative analysis of diffusion 
was possible (Figure 18).  
Stent  Parameter Implantation Explantation % Change 
Stents Mean 
Value 
SD Stents Mean 
Value 
SD 
AMS Stent Area 5 8.00 1.05 4 5.93 0.48 - 26 
 Strut Number 5 6.38 1.22 4 4.45 1.47 - 30 
 Strut 
Thickness 
5 0.20 0.03 4 0.15 0.02 - 30 
 Max Lumen 
Diameter 
5 3.16 1.19 4 2.88 0.46 - 16 
 Min Lumen 
Diameter 
5 2.88 0.19 4 2.69 0.37 - 3 
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Figure 17A,B: Note the yellow magnesium struts surrounded by bluish-violet displayed endothelium. The yellow 
hue (*) around the AMS struts demonstrates the diffusion of the magnesium into the surrounding tissue. 
Photographed on a fluorescence microscope (Zeiss Axiotech Vario, Germany) with a camera (AxioCam HSm, 
Carl Zeiss Germany) and DAPI-filter. 
 
  
Figure 18A,B: The stain was no longer strong enough to capture the diffusion of the magnesium particles, but 
strong enough to identify the struts. Photographed on a fluorescence microscope (Zeiss Axiotech Vario, Germany) 
with a camera (AxioCam HSm, Carl Zeiss Germany) and DAPI-filter. 
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Figure 19: Overview of the four different visualization techniques at time of explantation. (A) MPS: Single black 
AMS strut partially dissolved due to processing, is embedded within a thin endothelial coverage. (B) Titan yellow: 
Selective demonstration of AMS – note the yellow AMS on a bluish-violet background. (C) IVUS: Clear signs of 
degradation of the AMS, with a fainter appearance and a decline in distal acoustic shadowing. (D) OCT: AMS 
struts appear darker and more diffuse than at implantation – some struts seemed to have dissolved and had less 
discernible distal acoustic shadowing. 
Comparison of Imaging Techniques 
In-vivo: IVUS vs. OCT 
Both IVUS and OCT showed a qualitative indication of biodegradation by means of a 
signal reduction of AMS (Figure 20). With IVUS, the AMS appeared fainter and had 
less distal acoustic shadowing. Some AMS struts could barely be discerned from the 
vessel wall. With OCT, the AMS struts appeared darker and more diffuse. Some 
struts seemed to have dissolved, and had less discernible distal shadowing. OCT was 
also able to capture the endothelial coverage, stent apposition and neointima 
formation. 
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Figure 20: With IVUS (A), the AMS appeared fainter with less distal acoustic shadowing. With OCT (B), the 
AMS struts appeared darker and more diffuse. Some struts seemed to have dissolved, and had less discernible 
distal acoustic shadowing. OCT was also able to capture the endothelial coverage, stent apposition and neointima 
formation. 
Due to the limited analysis with OCT at implantation, IVUS and OCT were compared 
at the time of explantation by means of stent area, strut number, strut thickness and 
mean lumen diameter. 
The stent area comparison was performed by matching results from pairs of 77 cross-
sections. There was a significant (p<0.01) yet moderate correlation between the two 
methods (r=0.36). The AMS stent area measured by OCT was smaller than IVUS, 
while the BMS stent area was larger (Figure 21A, B, C). 
 
Figure 21A: Comparison of stent area as measured with IVUS and OCT. There was a significant (p<0.001) yet 
moderate correlation between the two methods (r=0.35). 
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Figure 21B:  Longitudinal comparison of AMS stent area as measured by IVUS and OCT. OCT measured a 
consistently smaller stent area for AMS. 
 
 
Figure 21C: Longitudinal comparison of BMS stent area measured by IVUS and OCT. OCT measured a 
consistently larger stent area for BMS. 
For the strut number comparison, measurements from 71 cross-sectional pairs of 
IVUS and OCT were used. For IVUS the mean strut number was 6.5±2.97, while for 
OCT this number was 6.07±2.20. The strut number varied due to the changing angle 
of the visualization of the cross-section, and therefore there is no correlation for this 
number between IVUS and OCT. The results, however, do point to OCT being able to 
visualize a larger number of AMS struts, but a smaller number of BMS struts (Figure 
22A, B). 
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Figure 22A: Longitudinal comparison of IVUS, OCT and histology by means of strut number. There was no 
significant correlation between these methods, though histology tended to capture more AMS struts than OCT, 
followed by IVUS. 
 
Figure 22B: Longitudinal comparison of IVUS and OCT by means of BMS strut number. There was no significant 
correlation between these methods, though IVUS tended to capture more BMS struts. 
Next, strut thickness was compared between 71 pairs of cross-sections. Results show 
that there is a negative moderate correlation between IVUS and OCT (r=-0.46, 
p<0.01), which indicates that the thicker a strut appears in IVUS, the thinner it is in 
OCT. The strut thickness for OCT was found to be smaller than the strut thickness for 
IVUS for both AMS and BMS (Figure 23A, B). 
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Figure 23A: Longitudinal comparison of IVUS and OCT by means of AMS strut thickness. The OCT strut 
thickness was consistently smaller than that measured by IVUS. 
 
Figure 23B: Longitudinal comparison of IVUS and OCT by means of BMS strut thickness. The OCT strut 
thickness was consistently smaller than that measured by IVUS. 
For comparison of mean lumen diameter, 73 pairs of cross-sections were used. There 
was a significant and moderate correlation between IVUS and OCT (r=0.36, p<0.01). 
The mean lumen diameter for OCT was smaller than that of IVUS (Figure 24A, B, 
C).  
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Figure 24A: Comparison of OCT vs. IVUS by means of mean lumen diameter. There was a significant and 
moderate correlation between the two methods (r=0.36, p<0.01). 
 
Figure 24B: Longitudinal comparison of IVUS, OCT and histology by means of AMS lumen diameter. The mean 
lumen diameter for OCT and histology was smaller than that of IVUS (IVUS>OCT>histology). 
 
Figure 24C: Longitudinal comparison of IVUS and OCT by means BMS lumen diameter. The mean lumen 
diameter for OCT was smaller than that of IVUS. 
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IVUS and OCT (in-vivo) vs. Histology (ex-vivo) 
Histology offered a highly detailed assessment of the AMS-stented coronary vessels. 
Not only was a three-layered vessel wall able to be visualized thanks to Movat’s 
pentachrome staining, but it also helped us assess and understand the discrepancy 
between IVUS and OCT by displaying neointima and thrombus formations (Figure 
25, 26). 
 
 
Figure 25A, B, C: Comparison of in-vivo (A: IVUS, B: OCT) and ex-vivo (C: Histology with MPS) degradation 
visualization. While the in-vivo methods captured the biodegradation as a reduction of signal intensity of the AMS 
struts, the ex-vivo technique provided valuable information about the morphology of this degradation process. 
This comparison was only performed on AMS. Both the strut number and mean 
lumen area were compared with 19 pairs of cross-sections. 
While IVUS captured 4.45±1.47 struts, OCT captured 6.20±2.1, and histology 
captured 7.53±2.17. Due to changes in stent geometry as a function of the location of 
the cross-section, there was again no correlation between these three methods by 
!
A
!
B
!
C
- 40 -
means of strut number. Histology captured a larger strut number than OCT and IVUS 
(Figure 22A). 
There was no significant correlation for the mean lumen diameter between IVUS and 
histology. However, comparison of the mean lumen diameter between OCT and 
histology showed a significant and moderate correlation (r=0.74, p<0.01, see Figure 
25). IVUS tended to measure larger lumen diameters than OCT and histology 
(IVUS>OCT>histology, see Figure 24B). 
While comparing the three methods, it was interesting to see that IVUS consistently 
missed the neointima formation that was captured in both OCT and histology (Figure 
25). This finding helps us to understand the outliers of different method that possibly 
reduce the correlation.  
   
Figure 26: OCT (B) displayed a smaller lumen diameter in comparison to IVUS (A). As can be seen with histology 
(C), the lumen of this vessel was narrowed by an eccentric tissue proliferation consistent with neointima 
hyperplasia, which reinforced OCT’s assessment of the vessel. 
 
Figure 27: Comparison of histology and OCT by means of lumen diameter. This study showed a significant and 
moderate correlation between these two methods (r=0.74, p<0.01). 
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Assessment of Staining on Histological Morphometry 
Native vs. Stained Vessel Segment Comparison 
42 cross-sections were chosen at random, while 14 of them were destroyed during 
sample preparation (during cryosectioning, mounting, or staining) so that only 28 
cross-sections were left. 22 out of these 28 cross-sections contained AMS stented 
vessels, while the rest were reference segments without any stent implantation. 
Movat’s pentachrome was chosen as the stain and the properties of interest of the 
cross-sections were their: lumen area, intima area, vessel area, minimum and 
maximum lumen diameter, as well as their strut number and strut area. 
There was no noticeable size difference between the native and stained segments. In 
comparison to the images acquired with IVUS and OCT, the vessels were in an oval 
shape. One potential cause for this may have been the embedding process. All three 
layers of the vessel could be identified for both the native and stained cross-sections. 
Their internal elastic lamina (IEL) and external elastic lamina (EEL) appeared black 
in both methods, as did the stent struts, which were covered with a thin endothelial 
lining colored in red from the staining (Figure 28A, B). 
  
Figure 28: Comparison of native (A) and MPS (B) cross-sections of an AMS-stented segment. All three layers of 
the vessel could be identified for both the native and stained cross-sections. Their internal elastic lamina (IEL) and 
external elastic lamina (EEL) appeared black in both, as did the stent struts, which were covered with a thin 
endothelial lining colored in red from the staining. Furthermore, it was apparent that some struts were washed out 
during the staining and missing from the stained segments. 
Lumen Area 
The lumen area for the native cross-sections had a mean of 1.34±0.35 mm2 (range: 
0.75-2.10 mm2). The stained cross-sections had a lumen area with a mean of 
1.27±0.36 mm2 (range: 0.69-2.04 mm2). Neither group had a significant difference (p 
A B
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< 0.01) and their correlation was strong (r = 0.975) (Figure 29). 
  
Figure 29: Comparison of native and MPS cross-section by means of the lumen area. Neither group had a 
significant difference (p < 0.01) and their correlation was strong (r = 0.975). 
Intima Area 
The mean intima area for the native cross-sections was 2.20±0.78 mm2 (range: 1.31-
4.21 mm2) The stained intima area was meanwhile measured as 2.21±0.76 mm2 
(range: 1.28-4.23 mm2). The results also correlate strongly (r=0.975) and display no 
significant difference (p<0.01) (Figure 30). 
  
Figure 30: Comparison of native and MPS cross-sections by means of intima area. These results also correlate 
strongly (r=0.975) and display no significant difference (p<0.01). 
Vessel Area 
The vessel area for the native cohort turned out to be 3.5±0.72 mm2 (range: 2.45-5.14 
mm2). For the stained group, the mean vessel area was determined to be 3.58±0.75 
mm2 (range: 2.50-5.68 mm2). Again, there was no significant difference between 
groups (p<0.01) and they correlated strongly (r=0.98) (Figure 31). 
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Figure 31: Comparison of native and MPS cross-sections by means of the vessel area. There was no significant 
difference between groups (p<0.01) and they correlated strongly (r=0.98) 
Maximum Lumen Diameter
In order to calculate the maximum lumen diameter, the visually largest diameter was 
chosen. The mean maximum lumen diameter was 1.75±0.27 mm (range: 1.27-2.32
mm). For the stained cohort, their mean was 1.75±0.29 mm (range: 1.10-2.32 mm). 
There was no significant difference (p<0.01) and both methods correlated very well 
(r=0.918) (Figure 32). 
  
Figure 32: Comparison of native and MPS cross-sections by means of the maximum lumen diameter. There was 
no significant difference (p<0,01) and both methods correlated very well (r=0.918). 
Minimum Lumen Diameter 
The minimum lumen diameter was also determined by visual inspection. The mean 
value for the native group was 0.90±0.31 mm (range: 0.35-1.42 mm). The stained 
segments had a mean of 0.85±0.31 mm (range: 0.038-1.42 mm). There was no 
significant difference (p<0.01) and a strong correlation (r=0.923) between the two 
methods (Figure 33). 
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Figure 33: Comparison of native and MPS cross-sections by means of the minimum lumen diameter. There was no 
significant difference (p<0.01) and a strong correlation (r=0.923) between the two methods. 
Strut Number 
For the native cohort, there was a mean strut number of 8.18±2.78  (range: 3-25).  The 
mean strut number for the stained group was 6.95±3.06 (range: 5-14). The methods 
possessed no significant difference (p<0.01) and a moderate correlation 
(r=0.86)(Figure 34). 
  
Figure 34: Comparison of native and MPS cross-sections by means of the strut number. The methods possessed no 
significant difference (p<0.01) and a moderate correlation (r=0.86) 
Strut Area 
In order to determine strut area for each cohort, every single strut within a cross-
section was plotted and averaged. For the native group, the mean strut area was 
0.04±0.01 mm2 (range: 0.02-0.08 mm2).  For AMS, the mean strut area was 0.03±0.01 
mm2 (range: 0.02-0.06 mm2) for the stained group. The charts below illustrate no 
significant difference (p<0.01) and only a moderate correlation r=0.565 (Figure 35). 
The moderate correlation is most likely due to the fact that during cryosectioning 
some struts cracked and were partially washed away during staining (Figure 36).
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Figure 35: Comparison of native and MPS cross-sections by means of the strut area. The charts illustrate no 
significant difference (p<0.01) and only a moderate correlation r=0.565. 
  
Figure 36A, B: As can be seen in the image of the native cross-section (A), during cryosectioning some struts 
cracked and therefore during staining were partially washed away, as can be seen in the stained cross-section (B). 
Intra-observer Reproducibility 
To determine intra-observer reproducibility, the morphometry of the stained samples 
(the same ones from the comparison of native vs. stained study) was repeated three 
months later. Overall, the comparison showed an excellent significant correlation 
consistent with high intra-observer reproducibility. The calculated correlation for each 
different parameter was as followed: lumen area (κ=0.99, p<0.01), intima area 
(κ=0.98, p<0.01), media area (κ=0.99, p<0.01), maximum diameter (κ=0.99, p<0.01), 
minimum diameter (κ=0.99, p<0.01), strut number (κ=0.99, p<0.01). Only the strut 
area showed a moderate correlation (κ=0.75, p<0.01). 
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Discussion 
Animals, Safety and Feasibility 
Due to the similarity of their cardiovascular system to our own, Gottingen minipigs 
were chosen as subjects for this study71. One significant difference between the 
physiology of the heart of Gottingen minipigs and the human heart is their 
vulnerability to arrhythmia. During OCT acquisition, two out of the four minipigs had 
to be defibrillated after developing ventricular tachycardia due to ischemia in the 
examined area caused by the balloon occlusion.  
With IVUS, almost all vessels could be properly visualized. Only at time of 
explantation could one vessel not be examined because the guiding catheter was 
unable to pass the in-stent stenosis. Similar to other studies26, 31, there were no 
complications during this study. IVUS delivered a consistently high image quality, 
and as no complications occurred during image acquisition at time of implantation or 
explantation, the conditions were optimal while these vessels were visualized with 
this technique. 
Visualization with OCT was markedly more complicated. One vessel was dissected 
and occluded at time of implantation, so it was not possible to study this vessel later at 
the time of explantation. Though two animals developed ventricular fibrillation during 
occlusion at the time of implantation (only one of them could be successfully 
defibrillated), no arrhythmia complications occurred during explantation and all 
vessels but one could be visualized (the same vessel that could not be visualized with 
IVUS). One reason that no arrhythmia complications occurred at the time of 
explantation and only at implantation may be that the stent implantation and IVUS 
acquisition led to a spasmogen stimulus in the vessel – an effect missing at the time of 
explantation. In contrast to our own findings, Yamaguchi et al showed that while the 
occlusion technique in clinical settings led more frequently to transient events such as 
chest discomfort no major or acute procedural complications were observed82. Since 
OCT acquisition for this study was performed on healthy non-atherosclerotic vessels 
rather than the atherosclerotic vessels used in Yamaguchi’s study, it’s possible that 
these were more sensitive to spasmogen stimulus. And finally, since Kataiwa et al 
also demonstrated that in a comparison of non-occlusive and occlusive imaging 
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techniques for a small patient cohort (n=40) that the non-occlusive technique was 
safer42, for further research the non-occlusive method should be the preferred 
technique. It should also be noted that an animal model cannot be applied to humans 
without restrictions.  
The quantitative analysis with OCT was also more difficult than with IVUS. Due to 
the limited penetration depth of OCT, vessels with large lumens or thick walls could 
not be adequately assessed. Additionally, due to the sensitivity of its catheter tip, a 
consistently high image quality was not possible. Therefore not all the vessels 
visualized with the OCT could be assessed for vessel morphometry. So few were the 
number of samples at the time of implantation that no comparison could be made 
between implantation and explantation. 
While IVUS and OCT were used to visualize both AMS and BMS, histology was 
only performed on AMS due to the technical difficulties mentioned earlier. And since 
a few samples were destroyed during the preparation, this further reduced the number 
of cross-sections available to study 
Comparison of IVUS, OCT, and Histology 
Quantitative Assessment 
Histology offered a detailed assessment of the three-layered vessel anatomy and was 
also able to detect thrombus and neointima formation, as well as stent endothelization. 
Thanks to its high resolution, OCT clearly visualized the lumen-intima interface as a 
sharply defined border, and also clearly captured the neointima formation, stent 
endothelization and stent malapposition6, 9. OCT provides such a detailed assessment 
of tissue near struts because the light is unable to penetrate the struts, leading to weak 
signal reflections from struts, thus facilitating imaging46. IVUS, however, tended to 
miss these details since the ultrasound waves that are reflected from the struts 
interfere with those reflected from the surrounding tissue, resulting in the tissue 
around the struts not able to be properly visualized49. 
Both IVUS and OCT were able to visualize the biodegradation. A signal reduction of 
AMS struts was apparent in both methods. Inline with the Slottow et al findings61, the 
AMS struts appeared more diffuse and had less discernible distal acoustic shadowing 
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with OCT. At the time of explantation, IVUS presented AMS struts as poorly defined 
echolucent areas. Similar results were also observed in some other studies16, 23, 24, 80, 61. 
No change was detected for BMS with either technique. 
Vessel Morphometry 
Due to its consistently high image quality, IVUS was the only method that reliably 
visualized the stented coronary vessels along their whole length both at the time of 
implantation and explantation. Therefore IVUS was the only in-vivo technique 
available to us to compare stent dimensions acquired over the four weeks. It captured 
the biodegradation process as an overall reduction in stent area, strut number, strut 
thickness and lumen diameter for AMS, while there was no change detected in the 
BMS.  
Compared to OCT and histology, IVUS tended to overestimate AMS-stented vessel 
dimensions. Similar results, especially with respect to lumen area, were also shown by 
Suziki et al72 and Kawase et al43. This overestimation could be attributed to the 
difficulty in clearly identifying the lumen border in IVUS images due to blood 
speckle28, or the presence of artifacts such as side lobes (extraneous beams of 
ultrasound generated from the edges of individual transducer elements that are not in 
the direction of the main ultrasonic beam) that result from strut reflections49. The 
differing catheter diameters of the IVUS (1 mm) and OCT (0.4 mm) are also potential 
culprits. 
IVUS and OCT showed a moderate to good correlation by means of stent area, strut 
thickness and mean lumen diameter. One reason for the moderate correlation could be 
the different slice thicknesses of both methods (20 µm for OCT and 300 µm for 
IVUS), and the movement of the catheter in the beating heart that causes a variability 
of dimensions. Previous studies have shown that IVUS tends to overestimate larger 
vessels and underestimate the smaller ones68, though another explanation could be the 
calibration of the sensitive OCT catheter during image acquisition can affect the 
results. Some outliers – like vessels with neointima formations – led to extreme 
variation between the techniques because the resulting morphology change was 
detected by OCT and histology, but not by IVUS. This helps to understand why IVUS 
and histology did not correlate by means of lumen diameter, while OCT and histology 
did.  
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The strut number varied so highly between techniques likely due to the changing 
cross-sectional visualization angle and different slice thicknesses between techniques: 
IVUS (300 µm) > OCT (20 µm) > Histology (10 µm). This resulted in no correlation 
for strut number between any of the methods. Correlation aside, the longitudinal 
comparison did demonstrate that histology was able to capture more struts than OCT 
and IVUS (Histology>OCT>IVUS). One possible reason for IVUS capturing fewer 
struts may be due to a weaker reflection of the ultrasound from AMS. Thus, the 
echogenicity was slightly lower and clearly identifying AMS struts was at times 
difficult. It is also possible that IVUS underestimated the stent area due to this same 
limitation.  
Titan Yellow Stain 
The two existing in-vitro (the immersion and electrochemical tests) and in-vivo 
(IVUS and OCT) methods commonly used to study the biodegradation of magnesium 
stents are not able to capture the distribution of magnesium within the vessel. In order 
to capture this degradation pattern in a real-life setting we needed to identify a 
staining method that would selectively visualize magnesium. Due to its employment 
in previous successful studies and ease of use, we chose to work with titan yellow. 
The main limitation of staining AMS-stented vessels is that, as a biodegradable metal, 
the AMS might dissolve in the aqueous environment. For this reason we modified the 
titan yellow staining procedure to minimize the stents’ exposure to water and alcohol. 
This experiment helped us to selectively visualize the AMS struts and capture their 
degradation products diffusing into the surrounding tissue. This was the first study to 
show that biodegradable magnesium stents and their degradation products can be 
visualized in an ex-vivo study, which in turns allows us to use these images to 
compare and better understand the changes due to degradation during in-vivo 
visualization. The simplicity and speed of the titan yellow staining procedure also 
puts it at a large advantage over the in-vitro corrosion techniques previously 
employed. 
The only drawback to the titan yellow staining technique faced during this study was 
its decreased effectiveness of the staining procedure over time. This is an issue that 
should be investigated as the topic of another study. 
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Assessment of Staining on Histological Morphometry 
Overall there was a significant correlation between native and stained cross-sections 
by means of lumen area, intima area, vessel area, maximum and minimum lumen 
diameter. In 1985 Siegel et al demonstrated that histological preparation changed the 
vessel dimensions of atherosclerotic coronary vessels based on the extent of the 
atherosclerosis69. For vessels with minimal atherosclerotic narrowing, histological 
preparation decreased the total vessel and lumen cross-sectional areas, whereas it did 
not affect the absolute wall area. In contrast, for vessels with moderate to severe 
atherosclerosis, histological preparation decreased both the wall area and total cross-
sectional area while the lumen cross-sectional area stayed the same. The discrepancy 
between this study’s findings and those by Siegel et al can be explained by the 
differing subjects (in this study the vessels were stented and otherwise healthy) and 
methods of histological preparation (both staining and fixation methods differed) 17. 
Siegel et al used atherosclerotic coronary vessels and fixed them with formalin, so 
this set of results can complete each other. 
The comparison of native and stained cross-sections showed a moderate correlation 
by means of strut number and strut area. During cryosectioning some struts cracked 
and therefore during staining were partially washed away. While some examiners 
might be led to believe that a reduction in strut number and area is a clear indication 
of biodegradation, it’s in fact just a result of the staining process itself. Histology 
showed overall a very high intra-observer reproducibility. The only exception to this 
was the strut number, which showed a moderate correlation most likely due to the 
difficulty in determining the borders of individual struts after staining (caused by the 
wash-out effect). 
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Conclusion 
 
Biodegradable magnesium alloy stents (AMS) are a new and promising advancement 
in interventional cardiology. The human body absorbs these stents once they have 
served their mechanical purpose (temporary scaffolding) after about 2-3 months, 
allowing AMS to circumvent the existing adverse effects of stenting (such as late 
thrombosis, in-stent stenosis) and restore vasomotion. Now, with the aid of recent 
innovations (e.g. drug eluting absorbable metal stents), these stents may set a new 
standard for coronary stenting. 
The aim of this study was twofold: to study the available in-vivo visualization 
techniques (OCT and IVUS) in order to identify their strengths and weaknesses in 
assessing the biodegradation process of AMS better and compare those findings with 
histology, and secondly to identify a new histological technique to study the 
distribution of magnesium and its degradation products in to surrounding tissue upon 
biodegradation.  
Both IVUS and OCT are effective in-vivo visualization techniques to study the 
biodegradation process of AMS. IVUS is superior to OCT in capturing vessel 
morphometry thanks to its ease of use and consistently high image quality, thus 
enabling us to study the vessel dimensions during biodegradation. OCT, however, is a 
better technique for detailed vessel assessment thanks to its higher resolution, and 
helps us to detect the qualitative changes during biodegradation. Thanks to recent 
improvements in OCT (esp. non-occlusive techniques), better quantitative 
visualization with OCT can now be expected. 
Both in-vivo methods (OCT and IVUS) showed a moderate correlation. The 
histological studies showed a poorer correlation with these in-vivo techniques; 
measurements were consistently largest with IVUS and smallest with histology 
(IVUS > OCT > histology). Staining did not affect most stent measurements, and the 
reduction in strut number and area was likely due to the strut integrity compromised 
by cryosectioning and struts subsequently washed away during staining. As this effect 
could cause confusion in serial histology studies observing biodegradation, it is 
important to determine the washout effect of staining on struts for future studies. 
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Though IVUS and OCT together offer a gross understanding of AMS biodegradation, 
in order to complete this view at a cellular level one must employ a third technique. 
The technique investigated in this study was titan yellow staining, which proved to be 
a feasible method for capturing the biodegradation process and the distribution of 
magnesium within the vessel wall. This study showed for the first time that 
biodegradable magnesium stents and their degradation products can be visualized 
effectively ex-vivo, and analysis from these images will allow us to better understand 
changes due to degradation during in-vivo visualization. Its simplicity and speed 
make titan yellow preferred to the in-vitro corrosion techniques previously employed. 
The procedure, however, must be further modified in order to improve its 
effectiveness over a longer period of time. Once this is achieved, it will then be 
possible to measure the density of degradation products away from struts over time, 
so as to more thoroughly understand the degradation kinetics. 
 
 
 
 
 
 
 
 
 
 
 
	   - 53 -	  
Abstract 
 
Percutaneous coronary intervention (PCI) is the most common treatment for coronary 
artery disease (CAD). The first form of PCI introduced was balloon angioplasty. After 
that, the advent of coronary stents (tubular wire mesh for intravascular mechanical 
support) led to a new era in interventional cardiology. Through the implantation of 
bare metal stents (BMS), all three limitations of balloon angioplasty – coronary artery 
dissection, elastic recoil and negative remodelling – are prevented. Unfortunately, 
bare metal stents have their own drawbacks: most significantly, in-stent stenosis as a 
result of deep focal vascular injury caused by stent struts, followed by excessive 
tissue proliferation. This drawback has since been addressed with the introduction of 
drug eluting stents (DES). 
Both BMS and DES are permanent stents. As foreign bodies implanted into coronary 
vessels, they cause the following adverse effects: hypersensitivity reaction, chronic 
inflammation, elimination of vasomotion, and stent thrombosis. 
Biodegradable stents have been set forth as a candidate to overcome the drawbacks of 
permanent stents through providing temporary mechanical stability for a vulnerable 
lesion before complete degradation without long-term impairment of vessel function. 
The two main materials used in biodegradable stents are poly-L-lactide and metal (or 
AMS, short for absorbable metal stents). One type of AMS is magnesium alloy. 
 
Before AMS become a standard in the treatment of CAD, more research is required to 
better understand their degradation kinetics and mechanical stability. In order to 
complete these studies, however, the stents must provide adequate opacity for 
visualization – wherein lies the challenge. It is not possible to visualize magnesium 
stents with coronary angiography. Newer imaging modalities such as optical 
coherence tomography (OCT) and intravascular ultrasound (IVUS) have been 
proposed as techniques to visualize these stents and their biodegradation. 
The aim of this study was twofold: first, to study the available in-vivo visualization 
techniques (OCT and IVUS) in order to identify their strengths and weaknesses in 
assessing the biodegradation process of AMS through comparison with histology; and 
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secondly, to identify a new histological technique for studying the distribution of 
magnesium and its degradation products into surrounding tissue upon biodegradation. 
Four Gottingen mini pigs were implanted with AMS and BMS, and assessed with 
IVUS and OCT under fluoroscopic guidance at the time of implantation and prior to 
explantation (4 weeks later). Upon completion of the in-vivo studies, the hearts of the 
study objects were harvested for histological processing. 
 
Results showed that both IVUS and OCT are effective visualization techniques in 
studying the biodegradation process of AMS. IVUS is superior to OCT in capturing 
vessel morphometry thanks to its ease of use and consistently high image quality, thus 
enabling us to study vessel dimensions during biodegradation. OCT, however, is a 
better technique for detailed vessel assessment thanks to its higher resolution, and 
helps us to detect qualitative changes during biodegradation. The two methods 
correlate moderately during the morphometric analysis. The histological studies on 
the other hand showed a poorer correlation with the in-vivo techniques. This was 
likely due to strut integrity compromised during cryosectioning and subsequently 
washed away after staining, as in an adjunctive study we were able to show that 
staining did not affect morphometry. The measurements were consistently largest 
with IVUS, and the smallest with histology (IVUS > OCT > histology). 
Though IVUS and OCT together offer a gross understanding of AMS biodegradation, 
in order to complete this view at a cellular level one must employ a third technique. 
The technique investigated in this study was titan yellow staining, which proved to be 
a feasible method for capturing the biodegradation process and the distribution of 
magnesium within the vessel wall. This study showed for the first time that 
biodegradable magnesium stents and their degradation products can be visualized 
effectively ex-vivo, and that analysis of these images will allow us to better 
understand the changes due to degradation during in-vivo visualization. Its simplicity 
and speed make titan yellow preferred to the in-vitro corrosion techniques previously 
employed. The procedure, however, must be further modified in order to improve its 
effectiveness over a longer period of time. Once this is achieved, it will then be 
possible to measure the density of degradation products away from struts over time, 
so as to more thoroughly understand the degradation kinetics. 
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Zusammenfassung 
 
Die perkutane koronare Intervention (PCI, percutaneous coronary intervention) ist  
heute die Standardtherapie zur Behandlung der koronaren Herzerkrankung. War es in 
der Anfangszeit der PCI die alleinige Ballondilatation, so hat sich in den Folgejahren 
durch die Entwicklung von koronaren Stützprothesen (Stents) das Einsatzspektrum 
und die Anwendungssicherheit deutlich vergrößert. Durch die Einführung der Stents 
konnte Problemen wie der lumenobstruierende Dissektion sowie den elastischen 
Rückstellkräften (elastic recoil) wirkungsvoll begegnet werden. Ein wesentliches 
Problem dieser frühen Stentgenerationen war jedoch das Auftreten von Restenosen im 
Bereich der Stents, die im Wesentlichen durch ein überschiessendes Wachstum von 
Endothel- und glatten Muskelzellen bedingt waren. Um diesem Problem zu begegnen, 
wurden verschiedene Verfahren eingesetzt, von denen sich heute jedoch nur die 
Beschichtung der Stents mit proliferationshemmenden Substanzen (sog. drug eluting 
stents = DES) durchgesetzt hat.  
Ein wesentliches systemimmanentes Problem dieser Stents ist jedoch, dass durch die 
Stentimplantation Fremdmaterial permanent in die Koronargefäße eingebracht wird, 
das die Physiologie der Gefäßwand verändert und so z.B. zu chronischen 
Inflammationsreaktionen oder dem Auftreten von Thrombosen führen kann.  
Der Entwicklung von sog. biodegradierbaren Stents liegt daher die Überlegung zu 
Grunde, eine Technik bereitzustellen, die in der akuten Situation die mechanischen 
Vorteile von konventionellen Stents bietet und sich nach Behebung der akuten 
Situation, bzw. der Umwandlung einer „vulnerablen Läsion“ in eine stabile Läsion 
idealerweise rückstandsfrei auflöst.  
Um diese Eigenschaften zu erreichen, werden heute entweder Materialien auf 
Milchsäurebasis oder bestimmte Metalllegierungen (absorbable metal stents= AMS) 
auf Magnesiumbasis verwandt. 
Bei der Weiterentwicklung und Verbesserung dieser biodegradierbaren Stents kommt 
der koronaren Bildgebung eine wesentliche Rolle zu. Hiermit lassen sich wesentliche 
Eigenschaften der Stents während des Degradationsprozesses untersuchen. Die 
konventionelle Röntgendarstellung (Angiographie) ist aufgrund der geringen 
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Schwächung durch Magnesium oder auch Milchsäurederivate von untergeordneter 
Bedeutung. 
 Statt dessen kommen hier vorallem neuere intrakoronare Bildgebungsmethoden wie 
intravaskulärer Ultraschall (IVUS) oder die optische Kohärenztomographie( OCT) 
zum Einsatz.  
Ziel der vorliegenden Arbeit war es , die Abbildungseigenschaften von IVUS und 
OCT beim Degradationsprozess zu untersuchen und die erhaltenen Ergebnisse mit der 
histologischen Untersuchung zu vergleichen. Ausserdem sollte nach einer 
Möglichkeit gesucht werden, die Verteilung von Magnesium in der Gefäßwand, die 
im Rahmen des Degradationsprozesses stattfindet, mit histologischen Verfahren 
sichtbar zu machen. Für die experimentellen Untersuchungen am Tiermodell wurden 
insgesamt zehn AMS und BMS in vier Göttinger Minischweine implantiert und die 
Gefäße mittels IVUS und OCT bei Implantation und nach vier Wochen dargestellt. 
Anschließend erfolgte die histologische Evaluierung.  
Als ein wesentliches Ergebnis der Arbeit konnte gefunden werden, dass IVUS, wie 
auch OCT geeignet waren, den Prozess der Biodegradation darzustellen Bezüglich der 
Sicherheit und der Einfachheit der Anwendung war jedoch IVUS dem OCT deutlich 
überlegen. Im Gegenzug konnte mithilfe des OCT die Stentgeometrie, die Dicke der 
Neointima und auch Thrombusbildung sehr genau dargestellt werden. Beim Vergleich 
der beiden Methoden bezüglich der morphometrischen Stentanalyse konnte eine sehr 
hohe Übereinstimmung gefunden werden. Der Vergleich mit der nach Explantation 
durchgeführten Histologie lieferte bezüglich der quantitativen Parameter aber deutlich 
unterschiedliche Werte. Der Grund hierfür ist sicherlich in der komplizierten 
histologischen Aufarbeiten zu suchen, wenngleich ein substantieller Einfluß der 
eigentlichen Färbung durch eine dezidierte Substudie ausgeschlossen werden konnte.  
In der Tendenz lieferte der IVUS für die Gefäß- und Stentdimensionen im Schnitt die 
größten Werte, gefolgt von der OCT. Die morphometrische Analyse der 
histologischen Präparate ergab in der Regel die kleinsten Werte.  
Neben der morphometrischen Analyse war ein wesentlicher Aspekt der Arbeit der 
Versuch, die Abbauprodukte der AMS (im Wesentlichen elementares Magnesium) in 
ihrer Verteilung zu untersuchen. Hierzu wurde eine Modifikation einer Färbung nach 
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Kolthoff (Titan Gelb Färbung) entwickelt und an den vorliegenden Präparaten 
etabliert.  
Hierdurch konnte sehr schön die Deposition des elementaren Magnesiums in der 
näheren Umgebung der Stentstreben in der Gefäßwand nachgewiesen werden.  
Gleichwohl ist die Färbemethode in ihrer derzeitigen Anwendung nicht langzeitstabil 
und unterliegt noch größeren Schwankungen. Hier sind umfangreichere Studien 
notwendig um die diese Färbetechnik noch besser zu standardisieren und ggf. neben 
einer qualitativen Aussage auch noch eine quantitative Analyse der 
Magnesiumablagerung zu erhalten.  
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